| Medicare Wellpoint Federal | Billing and Coding: Hyaluronans Intra-articular Injections of (52420) | 2026-07-14 |
| Medicare Wellpoint Federal | Billing and Coding: Ibandronate Sodium (52421) | 2026-07-14 |
| Medicare Wellpoint Federal | Billing and Coding: Infliximab and biosimilars (52423) | 2026-07-14 |
| Medicare Wellpoint Federal | Health and Behavior Assessment/Intervention – Medical Policy Article (52434) | 2026-07-14 |
| Medicare Wellpoint Federal | Laparoscopic Sleeve Gastrectomy (LSG) – Medical Policy Article (52447) | 2026-07-14 |
| Medicare Wellpoint Federal | Billing and Coding: Omalizumab and biosimilar, OMLYCLO® (omalizumab-igec) (52448) | 2026-07-14 |
| Medicare Wellpoint Federal | Billing and Coding: Paclitaxel (e.g., Taxol®/Abraxane ™) (52450) | 2026-07-14 |
| Medicare Wellpoint Federal | Billing and Coding: Luteinizing Hormone-Releasing Hormone (LHRH) Analogs (52453) | 2026-07-14 |
| Medicare Wellpoint Federal | Psychological Services Coverage under the Incident to Provision for Physicians and Non-physicians – Medical Policy Article (52825) | 2026-07-14 |
| Medicare Wellpoint Federal | Blepharoplasty - Medical Policy Article (52837) | 2026-07-14 |